Literature DB >> 6681772

Vascular occlusion and tumour cell death.

J Denekamp, S A Hill, B Hobson.   

Abstract

Vascular occlusion has been tested as a means of inducing regrowth delay, local control, reduced cell viability and prolonged alteration of blood flow in mouse tumours. The occlusion has been achieved by applying D-shaped metal clamps across the base of subcutaneously implanted tumours. The period of clamping has been varied from 30 min to 24 hr. Marked tumour regression, delayed growth and long-term tumour control were seen, with the magnitude of the response being proportional to the duration of clamping. Vessel occlusion for at least 15 hr is necessary to achieve local cure of the tumour. The overall effect results partly from an immediate loss of cell viability and partly from a failure of the capillary network to recover its normal perfusion pattern after the clamp has been removed. The implications of this for anti-proliferative endothelial therapy is discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6681772     DOI: 10.1016/0277-5379(83)90426-1

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  32 in total

Review 1.  Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies.

Authors:  Chryso Kanthou; Gillian M Tozer
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

2.  The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models.

Authors:  Céline Clémenson; Erwan Jouannot; Ana Merino-Trigo; Chantal Rubin-Carrez; Eric Deutsch
Journal:  Invest New Drugs       Date:  2012-07-19       Impact factor: 3.850

3.  Antivascular ultrasound therapy extends survival of mice with implanted melanomas.

Authors:  Andrew K W Wood; Susan M Schultz; William M-F Lee; Ralph M Bunte; Chandra M Sehgal
Journal:  Ultrasound Med Biol       Date:  2010-04-09       Impact factor: 2.998

Review 4.  The contribution of women to radiobiology: Marie Curie and beyond.

Authors:  Anna Gasinska
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-29

5.  Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents.

Authors:  Casey J Maguire; Zhi Chen; Vani P Mocharla; Madhavi Sriram; Tracy E Strecker; Ernest Hamel; Heling Zhou; Ramona Lopez; Yifan Wang; Ralph P Mason; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2018-08-24       Impact factor: 3.597

Review 6.  Antiangiogenesis as a novel therapeutic concept in pediatric oncology.

Authors:  L Schweigerer
Journal:  J Mol Med (Berl)       Date:  1995-10       Impact factor: 4.599

7.  Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.

Authors:  M R Horsman; D J Chaplin; S A Hill; S Arnold; D Collingridge; M Radacic; P J Wood; J Overgaard
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 8.  Vascular attack as a therapeutic strategy for cancer.

Authors:  J Denekamp
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

Review 9.  The biology of the combretastatins as tumour vascular targeting agents.

Authors:  Gillian M Tozer; Chryso Kanthou; Charles S Parkins; Sally A Hill
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

10.  A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs.

Authors:  K Hori; S Saito; K Kubota
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.